Latest Articles

31. 07. 2020

List of reimbursed medicinal products valid as of 1.8.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

17. 07. 2020

Questions and Answers on the Use of Advanced Therapy Medicinal Products with Out-of-Specification Release Test Results

State Institute for Drug Control issues Questions and Answers document to clarify possibility of administration of advanced therapy medicinal products (ATMPs) in case...

 

30. 06. 2020

List of reimbursed medicinal products valid as of 1.7.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

29. 05. 2020

List of reimbursed medicinal products valid as of 1.6.2020

Acting in compliance with Section 39n(1) of Act No. 48/1997 Coll., on Public Health Insurance, as amended (“Act”), the State Institute for Drug Control publishes the List of...

 

13. 05. 2020

HOME CARE

Conditions under which it will be possible to include “ Home Care ” into the conduct of clinical trials also outside the period of COVID-19 pandemics.

 

12. 05. 2020

Brexit – on 7 May 2020, the European Commission published an updated notice to stakeholders

„WITHDRAWAL OF THE UNITED KINGDOM AND EU RULES IN THE FIELD OF CLINICAL TRIALS“ 

 

05. 05. 2020

SÚKL is involved in Simultaneous National Scientific Advice (SNSA) Pilot Project

EU-Innovation Network, who`s member is also State Institute for Drug Control (SÚKL), announced launch of Simultaneous National Scientific Advice (SNSA) Pilot Project. SÚKL...